MYH2 and head and neck squamous cell carcinoma: On the contrary, the expression of MYH2 had the most obvious downregulation, which was proved as a marker in distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma (Vachani et al., 2007).